Article
Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome.
Gene therapy - 1 Sept 2022
Huang Sida, Song Jian, He Chufeng, Cai Xinzhang, Yuan Kai, Mei Lingyun, Feng Yong
Abstract excerpt
Waardenburg syndrome (WS), also known as auditory-pigmentary syndrome, is the most common cause of syndromic hearing loss (HL), which accounts for approximately 2-5% of all patients with congenital hearing loss. WS is classified into four subtypes depending on the clinical phenotypes. Currently, pathogenic mutations of PAX3, MITF, SOX10, EDN3, EDNRB or SNAI2 are associated with different subtypes of WS. Although...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
